Texas HB 1033: Relating to prescription drug price disclosure; authorizing a fee; providing an administrative penalty.

Status: Effective on 9/1/21 (as of 2021-05-18)

State: Texas · Session: 87 · Bill: HB 1033

Subjects: HEALTH & HUMAN SERVICES COMMISSION (V0177), INTERNET (S0130), Insurance--Health & Accident (I0422), MEDICINE & PRESCRIPTION DRUGS (S7338), STATE HEALTH SERVICES, DEPARTMENT OF (V0463)

Sponsors: Hancock, Oliverson, Shaheen, Button, Guillen, Lopez, Morales Shaw, Tinderholt

View Texas HB 1033 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.